De Divitiis, C <br/><br/>
Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma.  [electronic resource] 

 -  Journal of translational medicine  05 2016 
 - 113 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/s12967-016-0857-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Metronomic<br/>Animals<br/>Carcinoma, Neuroendocrine--diagnostic imaging<br/>Cell Differentiation--drug effects<br/>Dacarbazine--administration & dosage<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Temozolomide<br/>Tomography, X-Ray Computed